EFFECT OF ORTHOTOPIC LIVER-TRANSPLANTATION ON BONE-MINERAL CONTENT AND SERUM VITAMIN-D METABOLITES IN INFANTS AND CHILDREN WITH CHRONIC CHOLESTASIS

被引:14
作者
ARGAO, EA
BALISTRERI, WF
HOLLIS, BW
RYCKMAN, FC
HEUBI, JE
机构
[1] CHILDRENS HOSP,MED CTR,DEPT PEDIAT SURG,CINCINNATI,OH 45229
[2] MED UNIV S CAROLINA,DEPT PEDIAT,CHARLESTON,SC 29425
关键词
D O I
10.1016/0270-9139(94)90093-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Almost all infants and children with chronic cholestasis have osteopenia. We evaluated the effect of orthotopic liver transplantation on bone mineral content and serum 25(OH)-vitamin D-[25(OH)D]-of nine infants and children (five girls; age, 6 to 21 mo at the time of orthotopic liver transplantation) with end-stage liver disease resulting from chronic cholestasis. We hypothesized that after orthotopic liver transplantation, decreased bone mineral content will recover and the serum 25(OH)D level will either normalize or remain normal in those who were previously vitamin D deficient or sufficient, respectively. All had subnormal bone mineral content before transplant. On long-term follow-up (>4 mo) of seven patients, bone mineral content normalized in all between 6.5 and 19 mo after transplant, with a mean of 11.2 +/- 4.5 mo. In six patients with normal serum 25(OH)D levels before orthotopic liver transplantation, the serum 25(OH)D levels had declined markedly 1 to 2 mo after transplant, followed by return to normal by 3 to 6 mo. Low serum 25(OH)D levels (<15 ng/ml) in three patients before orthotopic liver transplantation normalized after transplant. Although there was no correlation between bone mineral content and serum 25(OH)D level before transplant, sustained normal serum 25(OH)D and 1,25(OH),D levels preceded or accompanied normalization of bone mineral content in the seven patients available for long-term follow-up. We conclude that (a) in infants and children younger than 2 yr with chronic cholestasis, bone mineral content normalizes approximately 11 mo after orthotopic liver transplantation. This normalization is preceded by a sustained period of normal serum 25(OH)D levels. (b) Normal baseline serum 25(OH)D levels decrease 1 to 2 mo after orthotopic liver transplantation, with subsequent normalization, whereas initially low serum 25(OH)D levels gradually normalize within 2 to 4 mo. We speculate that maintenance of normal serum 25(OH)D levels with oral vitamin D supplementation may enhance recovery of bone disease after orthotopic liver transplantation.
引用
收藏
页码:598 / 603
页数:6
相关论文
共 33 条
[1]   D-ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL-1000 SUCCINATE ENHANCES THE ABSORPTION OF VITAMIN-D IN CHRONIC CHOLESTATIC LIVER-DISEASE OF INFANCY AND CHILDHOOD [J].
ARGAO, EA ;
HEUBI, JE ;
HOLLIS, BW ;
TSANG, RC .
PEDIATRIC RESEARCH, 1992, 31 (02) :146-150
[2]  
ARGAO EA, 1993, PEDIATRICS, V91, P1151
[3]  
ARNOLD JC, 1992, TRANSPLANT P, V24, P2709
[4]   EFFECTS OF PREDNISONE ON VITAMIN D METABOLISM IN MAN [J].
AVIOLI, LV ;
BIRGE, SJ ;
LEE, SW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1968, 28 (09) :1341-+
[5]   GROWTH-HORMONE INSENSITIVITY ASSOCIATED WITH ELEVATED CIRCULATING GROWTH HORMONE-BINDING PROTEIN IN CHILDREN WITH ALAGILLE SYNDROME AND SHORT STATURE [J].
BUCUVALAS, JC ;
HORN, JA ;
CARLSSON, L ;
BALISTRERI, WF ;
CHERNAUSEK, SD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (06) :1477-1482
[6]   EFFECT OF PREDNISOLONE UPON METABOLISM AND ACTION OF 25-HYDROXYVITAMIN-D3 AND 1,25-DIHYDROXYVITAMIN-D3 [J].
CARRE, M ;
AYIGBEDE, O ;
MIRAVET, L ;
RASMUSSEN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (08) :2996-3000
[7]   SELECTIVE-INHIBITION OF MITOCHONDRIAL 27-HYDROXYLATION OF BILE-ACID INTERMEDIATES AND 25-HYDROXYLATION OF VITAMIN-D3 BY CYCLOSPORINE-A [J].
DAHLBACKSJOBERG, H ;
BJORKHEM, I ;
PRINCEN, HMG .
BIOCHEMICAL JOURNAL, 1993, 293 :203-206
[8]   INTESTINAL-ABSORPTION AND 25-HYDROXYLATION OF VITAMIN-D IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS [J].
DANIELSSON, A ;
LORENTZON, R ;
LARSSON, SE .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1982, 17 (03) :349-355
[9]  
EPSTEIN S, 1989, CALCIFIED TISSUE INT, V47, P152
[10]   EFFECTS OF PREDNISONE AND DEFLAZACORT ON MINERAL METABOLISM AND PARATHYROID-HORMONE ACTIVITY IN HUMANS [J].
GENNARI, C ;
IMBIMBO, B ;
MONTAGNANI, M ;
BERNINI, M ;
NARDI, P ;
AVIOLI, LV .
CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (03) :245-252